AAME 8-K
Atlantic American Corp (AAME)
8-K
2025-08-12
For: 2025-08-12
View Original
Added on
April 09, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of report (Date of earliest event reported)
|
|
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code
|
(
|
|
N/A
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.02. |
Results of Operations and Financial Condition
|
On August 12, 2025, Atlantic American Corporation (the “Registrant”) reported its results of operations for its second quarter ended June 30, 2025. A copy of the press
release issued by the Registrant concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
| Item 9.01. |
Financial Statements and Exhibits
|
(d) Exhibits
|
Exhibit
Number
|
Description of Exhibit
|
|
|
Press release dated August 12, 2025.
|
||
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Registrant, whether made before or after
the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing. The information in this report, including the exhibit hereto, shall not be deemed to be “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
|
ATLANTIC AMERICAN CORPORATION
|
||
|
By:
|
/s/ J. Ross Franklin
|
|
|
J. Ross Franklin
|
||
|
Vice President, Chief Financial Officer and Secretary
|
||
|
Date: August 12, 2025
|
||
Exhibit 99.1
ATLANTIC AMERICAN CORPORATION REPORTS
SECOND QUARTER RESULTS FOR 2025
ATLANTA, Georgia, August 12, 2025 - Atlantic American Corporation (Nasdaq- AAME) today reported net income of $3.3 million, or $0.15 per diluted share, for the three
month period ended June 30, 2025 compared to net loss of ($0.7) million, or ($0.04) per diluted share, for the comparable period in 2024. The Company had net income of $4.1 million, or $0.19 per diluted share, for the six month period ended June
30, 2025, compared to net loss of ($2.7) million, or ($0.14) per diluted share, for the six month period ended June 30, 2024. The increase in net income for the three month and six month periods ended June 30, 2025 was primarily the result of
increases in premium revenue, coupled with an increase in unrealized gains on equity securities.
Operating income increased $2.7 million in the three month period ended June 30, 2025 from the three month period ended June 30, 2024. For the six month period ended
June 30, 2025, operating income increased $5.4 million from the comparable period in 2024. The increase in operating income for the three month and six month periods ended June 30, 2025 was primarily the result of increases in premium revenue
within the inland marine line of business in the property and casualty operations, as well as increases in the Medicare supplement and group accident and health lines of business within the life and health operations.
Commenting on the results, Hilton H. Howell, Jr., Chairman, President and Chief Executive Officer, stated, “We are pleased to report exceptional financial results this
quarter, marked by a significant increase in net income and continued improvement in operating income. Our property & casualty and life & health segments each delivered strong earned premium growth, supported by steady new business momentum
and retention of existing contracts. These results underscore the resilience of our business model, the effectiveness of our growth strategy and the benefits of our diversified product offerings. Looking ahead to the second half of the year, we
believe we are well-positioned to deliver sustained, profitable growth and drive long-term value creation for our shareholders.”
Atlantic American Corporation is an insurance holding company involved through its subsidiary companies in specialty markets of the life, health,
and property and casualty insurance industries. Its principal insurance subsidiaries are American Southern Insurance Company, American Safety Insurance Company, Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and
Atlantic Capital Life Assurance Company.
Note regarding non-GAAP financial measure: Atlantic American Corporation presents its consolidated financial statements in accordance with U.S.
generally accepted accounting principles (GAAP). However, from time to time, the Company may present, in its public statements, press releases and filings with the Securities and Exchange Commission, non-GAAP financial measures such as operating
income (loss). We define operating income (loss) as net income (loss) excluding: (i) income tax expense (benefit); (ii) realized investment (gains) losses, net; and (iii) unrealized (gains) losses on equity securities, net. Management believes
operating income (loss) is a useful metric for investors, potential investors, securities analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of
management (such as income tax expense (benefit), which is subject to timing, regulatory and rate changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operating results (such
as any realized and unrealized investment gains (losses), which are not a part of the Company’s primary operations and are, to a limited extent, subject to discretion in terms of timing of realization). The financial data attached includes a
reconciliation of operating income (loss) to net income (loss), the most comparable GAAP financial measure. The Company’s definition of operating income (loss) may differ from similarly titled financial measures used by others. This non-GAAP
financial measure should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.
Note regarding forward-looking statements: Except for historical information contained herein, this press release contains forward-looking statements that involve a number of risks and
uncertainties. Actual results could differ materially from those indicated by such forward-looking statements due to a number of factors and risks, including, among others: the effects of macroeconomic conditions and general economic uncertainty;
unexpected developments in the health care or insurance industries affecting providers or individuals, including the cost or availability of services, or the tax consequences related thereto; disruption to the financial markets; unanticipated
increases in the rate, number and amounts of claims outstanding; our ability to remediate the identified material weakness in our internal control over financial reporting; the level of performance of reinsurance companies under reinsurance
contracts and the availability, pricing and adequacy of reinsurance to protect the Company against losses; changes in the stock markets, interest rates or other financial markets, including the potential effect on the Company’s statutory capital
levels; the uncertain effect on the Company of regulatory and market-driven changes in practices relating to the payment of incentive compensation to brokers, agents and other producers; the potential impact of public health emergencies; the
incidence and severity of catastrophes, both natural and man-made; the possible occurrence of terrorist attacks; stronger than anticipated competitive activity; unfavorable judicial or legislative developments; the potential effect of regulatory
developments, including those which could increase the Company’s business costs and required capital levels; the Company’s ability to distribute its products through distribution channels, both current and future; the uncertain effect of emerging
claim and coverage issues; the effect of assessments and other surcharges for guaranty funds and other mandatory pooling arrangements; information technology system failures or network disruptions; risks related to cybersecurity matters, such as
breaches of our computer network or those of other parties or the loss of or unauthorized access to the data we maintain; and those other risks and uncertainties detailed in statements and reports that the Company files from time to time with the
Securities and Exchange Commission. As a result, undue reliance should not be placed upon forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to publicly update any forward-looking
statements as a result of subsequent developments, changes in underlying assumptions or facts or otherwise, except as may be required by law.
|
For further information contact:
|
|
|
J. Ross Franklin
|
Hilton H. Howell, Jr.
|
|
Chief Financial Officer
|
Chairman, President & CEO
|
|
Atlantic American Corporation
|
Atlantic American Corporation
|
|
404-266-5580
|
404-266-5505
|
Atlantic American Corporation
Financial Data
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
(Unaudited; In thousands, except per share data)
|
2025
|
2024
|
2025
|
2024
|
||||||||||||
|
Insurance premiums
|
||||||||||||||||
|
Life and health
|
$
|
29,005
|
$
|
27,449
|
$
|
57,587
|
$
|
54,123
|
||||||||
|
Property and casualty
|
21,141
|
17,544
|
39,472
|
35,422
|
||||||||||||
|
Insurance premiums, net
|
50,146
|
44,993
|
97,059
|
89,545
|
||||||||||||
|
Net investment income
|
2,516
|
2,416
|
4,958
|
4,972
|
||||||||||||
|
Realized investment gains, net
|
16
|
13
|
16
|
13
|
||||||||||||
|
Unrealized gains on equity securities, net
|
2,609
|
243
|
3,376
|
129
|
||||||||||||
|
Other income
|
3
|
3
|
6
|
6
|
||||||||||||
|
Total revenue
|
55,290
|
47,668
|
105,415
|
94,665
|
||||||||||||
|
Insurance benefits and losses incurred
|
||||||||||||||||
|
Life and health
|
17,634
|
17,579
|
34,950
|
36,691
|
||||||||||||
|
Property and casualty
|
16,013
|
14,228
|
30,610
|
27,041
|
||||||||||||
|
Insurance benefits and losses incurred, net
|
33,647
|
31,807
|
65,560
|
63,732
|
||||||||||||
|
Commissions and underwriting expenses
|
12,870
|
11,584
|
24,550
|
24,250
|
||||||||||||
|
Interest expense
|
773
|
867
|
1,547
|
1,722
|
||||||||||||
|
Other expense
|
3,784
|
4,259
|
8,507
|
8,316
|
||||||||||||
|
Total benefits and expenses
|
51,074
|
48,517
|
100,164
|
98,020
|
||||||||||||
|
Income (loss) before income taxes
|
4,216
|
(849
|
)
|
5,251
|
(3,355
|
)
|
||||||||||
|
Income tax expense (benefit)
|
900
|
(165
|
)
|
1,133
|
(673
|
)
|
||||||||||
|
Net income (loss)
|
$
|
3,316
|
$
|
(684
|
)
|
$
|
4,118
|
$
|
(2,682
|
)
|
||||||
|
Earnings (loss) per common share (basic)
|
$
|
0.16
|
$
|
(0.04
|
)
|
$
|
0.19
|
$
|
(0.14
|
)
|
||||||
|
Earnings (loss) per common share (diluted)
|
$
|
0.15
|
$
|
(0.04
|
)
|
$
|
0.19
|
$
|
(0.14
|
)
|
||||||
|
Reconciliation of non-GAAP financial measure
|
||||||||||||||||
|
Net income (loss)
|
$
|
3,316
|
$
|
(684
|
)
|
$
|
4,118
|
$
|
(2,682
|
)
|
||||||
|
Income tax expense (benefit)
|
900
|
(165
|
)
|
1,133
|
(673
|
)
|
||||||||||
|
Realized investment gains, net
|
(16
|
)
|
(13
|
)
|
(16
|
)
|
(13
|
)
|
||||||||
|
Unrealized gains on equity securities, net
|
(2,609
|
)
|
(243
|
)
|
(3,376
|
)
|
(129
|
)
|
||||||||
|
Non-GAAP operating income (loss)
|
$
|
1,591
|
$
|
(1,105
|
)
|
$
|
1,859
|
$
|
(3,497
|
)
|
||||||
|
June 30,
|
December 31,
|
|||||||
|
Selected balance sheet data
|
2025
|
2024
|
||||||
|
Total cash and investments
|
$
|
280,282
|
$
|
265,696
|
||||
|
Insurance subsidiaries
|
274,443
|
258,675
|
||||||
|
Parent and other
|
5,839
|
7,021
|
||||||
|
Total assets
|
429,339
|
393,428
|
||||||
|
Insurance reserves and policyholder funds
|
255,513
|
225,106
|
||||||
|
Debt
|
37,759
|
37,761
|
||||||
|
Total shareholders' equity
|
106,168
|
99,613
|
||||||
|
Book value per common share
|
4.94
|
4.61
|
||||||
|
Statutory capital and surplus
|
||||||||
|
Life and health
|
34,642
|
32,443
|
||||||
|
Property and casualty
|
47,183
|
47,670
|
||||||